Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus

被引:7
|
作者
Gomez-Gutierrez, Jorge G. [1 ]
Rao, Xiao-Mei [1 ,2 ]
Zhou, Heshan Sam [1 ,2 ]
McMasters, Kelly M. [1 ,2 ]
机构
[1] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA
[2] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
关键词
Lung; Cancer; Virotherapy; E2Ftr; Apoptosis; In vivo; CONDITIONALLY REPLICATING ADENOVIRUS; EFFICIENTLY INDUCES APOPTOSIS; TRANSCRIPTION FACTOR; IN-VIVO; GENE-TRANSFER; MELANOMA-CELLS; CYCLIN-E; DEFECTIVE ADENOVIRUS; LUNG-CANCER; S-PHASE;
D O I
10.1016/j.virol.2012.09.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adenovirus-mediated gene transfer into a tumor mass can be improved by combining it with conditionally-replicating adenovirus (CRAd) when both vectors co-infect the same cancer cell. We investigated the efficiency of enhancing transgene expression and effectiveness of cancer killing of two advenoviruses (Ads), one expressing E2F-1 (AdE2F-1) and another expressing a truncated form of E2F-1 that lacks the transactivation domain (AdE2Ftr), when combined with oncolytic Adhz60. We found that AdE2F-1 with Adhz60 actually decreased E2F-1 expression and viral replication through a mechanism apparently involving repression of the cyclin-E promoter and decreased expression of early and late structural proteins necessary for viral replication. In contrast, AdE2Ftr with Adhz60 resulted in increased E2Ftr expression, AdE2Ftr replication, and cancer cell death both in vitro and in vivo. These results indicate that AdE2Ftr coupled with a CRAd enhances AdE2Ftr-mediated cancer cell death. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 50 条
  • [1] Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus (vol 433, pg 538, 2012)
    Gomez-Gutierrez, Jorge G.
    Rao, Xia-Mei
    Zhou, Heshan Sam
    Mcmasters, Kelly M.
    VIROLOGY, 2024, 595
  • [2] Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus
    Yan, Yang
    Xu, Hu
    Wang, Jiandong
    Wu, Xin
    Wen, Wei
    Liang, Yan
    Wang, Lingdi
    Liu, Fengyuan
    Du, Xiaohui
    BIOSCIENCE REPORTS, 2019, 39
  • [3] Adenovirus-mediated expression of truncated E2F-1 suppresses tumor growth in vitro and in vivo
    Gomez-Gutierrez, Jorge G.
    Garcia-Garcia, Aracely
    Hao, Hongying
    Rao, Xiao-Mei
    de Oca-Luna, Roberto Montes
    Zhou, Heshan S.
    McMasters, Kelly M.
    CANCER, 2024, 130 (17) : 3047 - 3047
  • [4] Adenovirus-Mediated Expression of Truncated E2F-1 Suppresses Tumor Growth In Vitro and In Vivo
    Gomez-Gutierrez, Jorge G.
    Garcia-Garcia, Aracely
    Hao, Hongying
    Rao, Xiao-Mei
    Montes de Oca-Luna, Roberto
    Zhou, Heshan S.
    McMasters, Kelly M.
    CANCER, 2010, 116 (18) : 4420 - 4432
  • [5] Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model
    Yan, Yang
    Xu, Yingxin
    Zhao, Yunshan
    Li, Li
    Sun, Peiming
    Liu, Hailiang
    Fan, Qinghao
    Liang, Kai
    Liang, Wentao
    Sun, Huiwei
    Du, Xiaohui
    Li, Rong
    TUMOR BIOLOGY, 2014, 35 (02) : 1113 - 1122
  • [6] Combination of oncolytic adenoviral therapy with chemotherapy for enhanced breast cancer cell killing - Virotherapy in combination with chemotherapy
    Jung, J.
    Nedeljkovic-Kurepa, A.
    Glover, B.
    Curiel, D. T.
    Schmutzler, R. K.
    Mathis, J. M.
    Stoff-Khalili, M. A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S62 - S62
  • [7] Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus (vol 39, pg , 2019)
    Yan, Yang
    Xu, Hu
    Wang, Jiandong
    Wu, Xin
    Wen, Wei
    Liang, Yan
    Wang, Lingdi
    Liu, Fengyuan
    Du, Xiaohui
    BIOSCIENCE REPORTS, 2020, 40
  • [8] Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1
    Darbinian, N
    Gallia, GL
    Kundu, M
    Shcherbik, N
    Tretiakova, A
    Giordano, A
    Khalili, K
    ONCOGENE, 1999, 18 (46) : 6398 - 6402
  • [9] Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1
    Nune Darbinian
    Gary L Gallia
    Mondira Kundu
    Natalia Shcherbik
    Anna Tretiakova
    Antonio Giordano
    Kamel Khalili
    Oncogene, 1999, 18 : 6398 - 6402
  • [10] A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
    J J Rojas
    M Cascallo
    S Guedan
    A Gros
    J Martinez-Quintanilla
    A Hemminki
    R Alemany
    Gene Therapy, 2009, 16 : 1441 - 1451